Institut Paoli Calmettes Chronic Lymphatic Leukemia Database
NCT02869529 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4200
Last updated 2016-08-17
Summary
Database of Institut Paoli-Calmettes patients diagnosed with chronic lymphatic leukemia
Conditions
- Leukemia, Lymphocytic, Chronic, B-Cell
Interventions
- OTHER
-
Data collection
Sponsors & Collaborators
-
Institut Paoli-Calmettes
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2030-01-31
- Completion
- 2030-12-31
Countries
- France
Study Locations
More Related Trials
-
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
NCT02618109 ·Status: TERMINATED ·Phase: PHASE4
-
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
NCT06475469 ·Status: RECRUITING ·Phase: NA
-
Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
NCT00934986 ·Status: COMPLETED ·Phase: NA
-
Observatory of Prolymphocytic Leukemia T
NCT04411043 ·Status: RECRUITING
-
Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
NCT02896829 ·Status: COMPLETED
-
Italian Study of Patients With Lymphoma
NCT06814925 ·Status: RECRUITING
-
B-cell Chronic Lymphoid Malignancies Markers
NCT04952974 ·Status: UNKNOWN
-
Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
NCT02902874 ·Status: COMPLETED ·Phase: NA
-
Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia
NCT02520895 ·Status: COMPLETED
-
Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment
NCT01521689 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans
NCT01287923 ·Status: COMPLETED
-
Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)
NCT06416267 ·Status: NOT_YET_RECRUITING
-
Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma
NCT05298293 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Personalized Therapy of Precursor Lymphoid Neoplasms
NCT01665001 ·Status: UNKNOWN ·Phase: PHASE2
-
Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology
NCT01310946 ·Status: UNKNOWN
-
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
NCT06024694 ·Status: ACTIVE_NOT_RECRUITING
-
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?
NCT03681938 ·Status: UNKNOWN
-
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
NCT05865301 ·Status: RECRUITING
-
A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients
NCT04139252 ·Status: UNKNOWN
-
Tissue Collection for Biomarkers Determining Resistance to Ibrutinib
NCT02267590 ·Status: UNKNOWN
-
Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma
NCT01556035 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
NCT02302469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers
NCT01117142 ·Status: COMPLETED
-
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
NCT03265158 ·Status: UNKNOWN
-
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
NCT03571997 ·Status: UNKNOWN